子宮内膜症(Endometriosis)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Endometriosis - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Endometriosis Overview 11
Therapeutics Development 12
Pipeline Products for Endometriosis – Overview 12
Pipeline Products for Endometriosis – Comparative Analysis 13
Endometriosis – Therapeutics under Development by Companies 14
Endometriosis – Therapeutics under Investigation by Universities/Institutes 17
Endometriosis – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Endometriosis – Products under Development by Companies 22
Endometriosis – Products under Investigation by Universities/Institutes 24
Endometriosis – Companies Involved in Therapeutics Development 25
AbbVie Inc. 25
Addex Therapeutics Ltd 26
APAvadis Biotechnologies Srl 27
Astellas Pharma Inc. 28
Bayer AG 29
Dongkook Pharmaceutical Co., Ltd. 30
ElexoPharm GmbH 31
EndoCeutics, Inc. 32
Euroscreen S.A. 33
Evotec AG 34
Forendo Pharma Oy 35
GlaxoSmithKline plc 36
Isifer AB 37
Kissei Pharmaceutical Co., Ltd. 38
Lipicard Technologies Limited 39
Neurocrine Biosciences, Inc. 40
Orphagen Pharmaceuticals, Inc. 41
Philogen S.p.A. 42
PregLem SA 43
Repros Therapeutics Inc. 44
SK Chemicals Co., Ltd. 45
Takeda Pharmaceutical Company Limited 46
ValiRx Plc 47
Endometriosis – Therapeutics Assessment 48
Assessment by Monotherapy Products 48
Assessment by Combination Products 49
Assessment by Target 50
Assessment by Mechanism of Action 52
Assessment by Route of Administration 54
Assessment by Molecule Type 56
Drug Profiles 58
(anastrozole + levonorgestrel) – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
acolbifene hydrochloride + GnRH agonist + prasterone – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
ADX-68692 – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
ASP-1707 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
BAY-1026153 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
BAY-1128688 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
bentamapimod – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Drug to Inhibit C-Jun for Endometriosis – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
Drug to Target RERG for Endometriosis – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
Drugs for Endometriosis – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Drugs for Endometriosis and Uterine Fibroids – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
elagolix sodium – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
Endole – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
epelsiban besylate – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
ESN-364 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
EVE-104 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
F8IL-4 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
FP-5677 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
goserelin biosimilar – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
KLH-2109 – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
LT-6121 – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
Monoclonal Antibody to Antagonize Prolactin Receptor for Endometriosis – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
NCE-403 – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
Peptides for Cancer and Endometriosis – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Peptides to Inhibit Aminopeptidase A for Cancer and Endometriosis – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
PGL-2001 – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Recombinant Protein for Endometriosis and Ovarian Hyperstimulation Syndrome – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
relugolix – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Small Molecule to Antagonize GnRH for Endometriosis, Uterine Fibroids, and Oncology – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
Small Molecules to Antagonize Prostanoid EP2 and EP4 Receptors for Endometriosis – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
Small Molecules to Antagonize Steroidogenic Factor-1 for Endometriosis, Cancer and Cushing’s Disease – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
Small Molecules to Inhibit 17 Beta-HSD1 for Endometriosis – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
Small Molecules to Inhibit 17 Beta-Hydroxysteroid Dehydrogenase Type1 for Endometriosis and Estrogen Dependent Cancers – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
Small Molecules to Inhibit CD147 for Immunology, Oncology, Endometriosis and Arthritis – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
SR-16234 – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
Synthetic Peptide to Antagonize GPR54 for Womens Health, Male Health and Oncology – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
telapristone acetate – Drug Profile 98
Product Description 98
Mechanism of Action 98
R&D Progress 98
triptorelin pamoate biosimilar – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
VAL-201 – Drug Profile 102
Product Description 102
Mechanism of Action 102
R&D Progress 102
vilaprisan – Drug Profile 103
Product Description 103
Mechanism of Action 103
R&D Progress 103
VPE-001 – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
Endometriosis – Recent Pipeline Updates 105
Endometriosis – Dormant Projects 118
Endometriosis – Discontinued Products 120
Endometriosis – Product Development Milestones 121
Featured News & Press Releases 121
Apr 01, 2014: ValiRx Provides Updated On Anti-cancer Therapeutic VAL201 121
Mar 13, 2014: New drug candidate showed efficacy in human endometriosis samples 121
Oct 03, 2013: ValiRx Files Phase IB/dose escalation study for VAL201 121
Aug 29, 2013: Neurocrine Biosciences Announces the Start of Second Phase III Study of Elagolix in Endometriosis 122
Apr 25, 2013: ValiRx Receives Australian Patent For VAL201 123
Nov 13, 2012: Repros Presents Proellex Clinical Updates At Lazard Capital Markets 9th Annual Healthcare Conference 123
Oct 08, 2012: Repros Therapeutics’s Proellex Receives FDA Acceptance For Reclassification Of Clinical Hold Status 123
Aug 27, 2012: FDA Provides Recommendations For Phase II Protocol For Repros’ Proellex In Treatment Of Endometriosis 124
Jul 30, 2012: FDA Schedules Meeting With Repros To Discuss Phase II Protocol For Proellex For Treatment Of Endometriosis 125
Jul 16, 2012: FDA Provides Guidance To Repros For Conducting Phase II Study Of Proellex In Treatment Of Endometriosis 125
Appendix 126
Methodology 126
Coverage 126
Secondary Research 126
Primary Research 126
Expert Panel Validation 126
Contact Us 127
Disclaimer 127


【レポート販売概要】

■ タイトル:子宮内膜症(Endometriosis)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Endometriosis - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6032IDB
■ 調査対象地域:グローバル
  • 建設用塗料・コーティング剤の世界市場2016-2020
    Construction paints and coatings refer to any liquid surface covering applied on the interior or exterior of a structure for decorative or protective purposes. They help prevent cracks and rusting, check the proliferation of fungi and algae, and enhance the looks and lifespan of the structure. Technavio’s analysts forecast the global construction paints and coatings market to grow at a CAGR of 6.3 …
  • 自立生活支援(AAL)及びスマートホームの世界市場動向・予測(~2020)
    The smart home market is expected to grow from USD 25.38 Billion in 2015 to USD 56.18 Billion by 2020, at a CAGR of 17.2% between 2015 and 2020. The market for ambient assisted living is estimated to grow from USD 1.20 Billion in 2015 to USD 3.96 Billion by 2020. Assisted living products are useful for people with heart disease, stroke, diabetes, obesity, and arthritis among others and these are c …
  • 特殊化学品の世界市場:種類別(食品添加物、化粧品化学物質、水処理化学物質、繊維化学物質、建設化学物質、紙・パルプ化学物質、油田化学物質、インク添加物)
    The global specialty chemicals market was valued at $211.2 million in 2018, and is projected to reach $316.5 million by 2026, growing at a CAGR of 5.2% from 2019 to 2026. Specialty chemicals are particular chemical products that help in providing variety of effects to various industries that they cater to such as textile, ink additives, construction, oil & gas, cosmetics, and food among others. Sp …
  • 抗体薬物複合体(ADC)の世界市場:シアトルジェネティクス技術、ImmunoGen技術、Immunomedics技術
    About Antibody Drug Conjugates ADCs, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances. ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tissue. Antibodies are the proteins produced by B-cells (from bone marrow) in the immune system. These proteins a …
  • 金属セラミックス複合材(MMC)の世界市場2017-2021
    About Metal Matrix Composites Composites are a combination of two or more materials that have different properties. They have high stiffness and tensile strength, low density, high thermal and electrical conductivity, and adjustable coefficient of thermal expansion. They are also corrosion resistant and stable at high temperatures. Composites are classified based on matrix and filler materials. Te …
  • 世界のMES市場動向(2012-2016)
    TechNavio's analysts forecast the Global MES market to grow at a CAGR of 11.71 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to improve the decision-making system. The Global MES market has also been witnessing the development of web-based MES solutions. However, the reluctance in migrating to the latest technology could pose a challenge t …
  • Tinnitus:グローバル臨床試験レビューH2, 2013
    Tinnitus Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Tinnitus Global Clinical Trials Review, H2, 2013" provides data on the Tinnitus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tinnitus. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
  • フローラルフレーバーの世界市場2018-2022
    About Floral Flavors Floral flavors are flavoring ingredients and extracts that are obtained from natural flowers. Technavio’s analysts forecast the Global Floral Flavors Market 2018-2022 to grow at a CAGR of 9.95% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the Global Floral Flavors Market 2018-2022. To calculate the marke …
  • シングルループ調節計の世界市場展望2017-2026
    According to Stratistics MRC, the Global Single Loop Controller market is accounted for $93.98 million in 2017 and is expected to reach $120.50 million by 2026 growing at a CAGR of 2.8% during the forecast period. The introduction of hybrid high-temperature controllers as a substitute to a PLC device and growing savings toward power generation projects are some of the key factors driving the marke …
  • 世界の公衆安全におけるモバイルブロードバンド市場
    Wireless broadband plays a significant role in improving ability of public safety personnel to efficiently communicate and obtain critical information in the form of real-time videos, images, and other forms of data. The creation of a state-of-the-art nationwide wireless broadband network for public safety purpose ensures that the public safety benefits of wireless broadband are available througho …
  • 麦芽成分の世界市場:乾燥モルト抽出物、液体モルト抽出物、モルト粉末
    Global malt ingredients market was valued at $15,294.1 in 2014, and is projected to grow at a CAGR of 6.8% from 2015 to 2020. Malt ingredients are food additives that are used for flavor and color enhancement to modify or stabilize texture of food & beverage products. Increase in consumer awareness regarding the health benefits of malt ingredients and the wide range of applications it finds in the …
  • Arcan Resources Ltd.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Arcan Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Arcan Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
  • Centrica plc:石油・ガスの開発・生産動向及びコスト分析– 2012
    Centrica plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Centrica plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational d …
  • アジアの潤滑剤市場
    The Asia-Pacific lubricants market is segmented on the basis of type, application, and geography. The market data is provided with respect to volume (Tons) and value (USD Million). The Asia-Pacific Lubricants market was estimated at USD 70,555.2 million in 2015, and is projected to grow at a CAGR of 3.3% from 2015 to 2020. The Asia-Pacific lubricants market has been analyzed based on the current p …
  • 魚醤の世界市場2019-2023
    Global Fish Sauce Market: About this market Technavio’s fish sauce market analysis considers sales from both industrial and traditional fish sauce. Our analysis also considers the sales of fish sauce in APAC, Europe, North America, South America, and MEA. In 2018, the industrial fish sauce segment had a significant market share, and this trend is expected to continue over the forecast period. Fact …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。